Akorn, Inc. (NASDAQ:AKRX)

CAPS Rating: 3 out of 5

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.


Player Avatar OriginalBarnacle (84.31) Submitted: 8/23/2007 2:01:20 PM : Underperform Start Price: $7.55 AKRX Score: +30.50

P/b = 10.2
P/S = 12.7
No earnings
Margins are worse with increasing inventory.
Price change over 106%

Featured Broker Partners